Essential Biotechnology

Essential Biotechnology is dedicated to striking at the heart of cancer through innovative therapeutic approaches. With a focus on overcoming the limitations of past targeted molecular therapies, Essential Biotechnology has discovered a crucial molecule that regulates tumor cell survival, enabling cancer cells to withstand environmental stresses and chemotherapies.

Essential Biotechnology has developed monoclonal antibodies targeting this nexus, effectively killing cancer cells by restoring their sensitivity to stress. Preclinical studies have demonstrated the effectiveness of this approach, even in traditionally challenging Ras-driven cancers. Addressing multi-billion dollar clinical problems such as ovarian, lung, and pancreatic cancers, Essential Biotechnology offers a novel mechanism of action that synergizes with existing drugs, providing new hope for patients facing resistance to therapy. The primary address for Essential Biotechnology is Big Bend, wi 53103, US.

Essential Biotechnology is actively seeking industry partners with compatible pipelines to accelerate the clinical development of these groundbreaking antibodies. We invite the manager of Essential Biotechnology to create a customized and exclusive company showcase and product listing on our platform, further enhancing your company's visibility and commercial opportunities.